www.scosonline.com                                                          Spring/Summer 2006

 
 

2006 Fall Membership Meeting

Friday and Saturday,
August 18–19, 2006

DoubleTree Guest Suites
181 Church Street
Charleston

More info.

Abraxis
Bayer Pharmaceuticals Corp Onyx Pharmaceuticals
Bristol-Myers Squibb
Genentech, Inc.
GlaxoSmithKline
Lilly Oncology
Oncology Supply
International Oncology Network
Ortho Biotech
Pfizer
Roche Laboratories
sanofi-aventis
Cephalon
Millennium Pharmaceuticals
Pharmion

See full list of our sponsors.

Go to www.scosonline.com for answers to all your reimbursement questions.

Go to Drug Reimbursement Hotlines for a listing of reimbursement assistance programs for oncology-related services.

 
News You Can Use

Commercial Insurer Trends–Cost Control
Donating e-Prescribing Equipment and Services
CMS Extends Physician Election Deadline to CAP
Drugs in the News; New USP Indications
ASCO Annual Meeting Research Round-up
NCI Offers Course to Practices on Clinical Trials
Meet You in St. Louis: Bring a Colleague at Half Price


Commercial Insurer Trends–Cost Control

Reimbursement in 2006 is finding a new focus on the private payer market. Without much fanfare, we are noticing that private payers are quicker with the uptake of changes initiated by Medicare. In our oncology practices, we cannot understate the importance of payments from commercial health insurance to compensate for lower revenues received from Medicare and Medicaid. Practices that have paid close attention to commercial contracts and once sat at the table to negotiate reimbursement rates are losing bargaining power, and—along with those practices that paid little attention to the terms of their agreements—are being offered take-it-or-leave-it contracts.

While the decrease in the number of private payers certainly is affecting this trend, the momentum of the quality movement is also proving to be the driver for constraining reimbursement with little regard for the impact it has on practices. Oncology is especially at a disadvantage since there are so few oncologists employed by the payers and costs for the specialty are not clearly understood.

One of the latest trends we are noticing in the private payer world in 2006 is imaging cost control efforts. Private payers are adopting a policy that is intended to save billions of dollars on wasted, unnecessary, and inappropriate care. The payers are ramping up their preauthorization process for many imaging procedures that have increased explosively over the past few years. Some payers expect to see a 25 percent reduction in utilization of non-emergency imaging services by eliminating testing that they deem unnecessary and duplicative. This clamping down on utilization is a way to move reimbursement away from payment for services, which is what the current reimbursement model pays for, towards reimbursement for care that is recommended based on evidence to improve a condition.

Despite these trends, it is still important to develop strong relationships with the private payers in your market...

Read more.


 

Donating e-Prescribing Equipment and Services

Two proposed rules offer some protection to practitioners that donate software and services used for electronic prescription (e-prescription) systems to certain categories of individuals.

Read more.

CMS Extends Deadline for CAP

On May 31, 2006, the Centers for Medicare and Medicaid Services (CMS) announced an extension to the physician election period for the Medicare Part B Drug Competitive Acquisition Program (CAP). The extension began on June 3, 2006, and will continue through June 30, 2006. Physicians whose completed physician election forms are received by their local carrier and whose forms are postmarked on or after June 3, but no later than June 30, 2006, will begin participation in the CAP starting on August 1, 2006.
 

Drugs in the News; New USP Indications
  • Avastin® (bevacizumab) (Genentech, South San Francisco, Calif.) has received a new indication from the USP DI compendium for treatment of metastatic breast carcinoma, HER2-negative disease, first line therapy in combination with paclitaxel.
  • Eloxatin (oxaliplatin) (sanofi-aventis) has received a new indication from the USP DI compendium for the treatment of gastric carcinoma, advanced/ metastatic.
  • Gleevec (imatinib mesylate) (Novartis) has received a new indication from the USP DI compendium for the treatment of acute lymphoblastic leukemia, Philadelphia chromosome-positive, newly diagnosed, as part of combination therapy.

Read more.
 

ASCO Annual Meeting Research Round-up

Here are brief highlights of advances in cancer research presented at ASCO’s 2006 Annual Meeting.

Low blood levels of vitamin D may worsen bone loss associated with exemestane. Findings support the use of vitamin D as well as calcium supplementation for postmenopausal women in general, and for those receiving aromatase inhibitors in particular.  Read more.
 

NCI Offers Course to Oncology Practices on Incorporating Cancer Clinical Trials

Do you want to refer patients to cancer clinical trials but don’t know how? Are you new to conducting clinical trials in a practice setting but want to know more? If so, the National Cancer Institute (NCI) has a course for you.

"Incorporating Cancer Clinical Trials Into Your Practice" is a free Web-based tutorial for health care professionals—oncologists, family physicians, internists, nurses, and other clinical staff—who are new to the clinical trials process. The course emphasizes the importance of participating in cancer clinical trials and how to do so, either through patient referral or becoming a clinical trials investigator.

Click here to access the course.
 

Meet You in St. Louis: Bring a Colleague for Half Price

The Association of Community Cancer Centers (ACCC) will present its 23rd National Oncology Economics Conference in St. Louis, Mo., on Sept. 13-16, 2006. For every paying Society/ACCC-member registrant, you may bring a colleague at half price! But hurry. This offer is valid only until August 15. It does not apply to industry representatives and cannot be used in conjunction with any other promotional coupons or discounts.

This meeting offers the perfect opportunity for your entire cancer care team (physicians, nurses, administrator, and billers/coders) to strengthen their skills and network with their colleagues.

READ THE AGENDA AND REGISTER NOW! 
 


SCOS is a chapter member of the Association of Community Cancer Centers
and an affiliate of the American Society of Clinical Oncology.

© Copyright 2006 Association of Community Cancer Centers. All Rights Reserved
You are receiving this message because you are affiliated with ACCC
and we believe you will benefit from this information.